Bloomberg's John Lauerman has a rare JAK2 variant that is associated with cancer-like blood disorders, including myelofibrosis. He also has a APOE-C130R variant that increases his risk of Alzheimer's disease. Despite this, the 53-year-old Personal Genome Project participant says he considers himself fortunate.